There are two major causes of dry eye: aqueous deficiency and lipid deficiency.
Approximately half of all dry eye sufferers are lipid deficient, yet 90% of all
artificial tear products sold in Australia target aqueous deficiency. New Optive
Advanced Lubricant eye drops from Allergan, target lipid deficiency. Triple
action lipid enhanced drop provides the comfort of an aqueous tear with low blur:
lubrication that restores and stabilises tear film, osmoprotection to hydrate the
eye epithelium and lipid enhancement to reduce tear evaporation.
Stockists: Major wholesalers
RRP: $14.95 for Advanced 15 ml, $15.50 for Advanced Preservative-Free
Website: www.allergan.com.auThe above article was sent to subscribers in Pharmacy Daily's issue from 25 Jun 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 Jun 14
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.